William Blair Estimates Danaher’s FY2025 Earnings (NYSE:DHR)

Danaher Corporation (NYSE:DHR) – William Blair cut their FY2025 earnings per share estimates for Danaher in a research note issued to investors on Wednesday, October 22nd. William Blair analyst M. Larew now anticipates that the conglomerate will post earnings per share of $7.71 for the year, down from their prior forecast of $7.72. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. William Blair also issued estimates for Danaher’s Q4 2025 earnings at $2.14 EPS, Q1 2026 earnings at $2.00 EPS, Q2 2026 earnings at $1.97 EPS, Q3 2026 earnings at $1.99 EPS, Q4 2026 earnings at $2.38 EPS and FY2026 earnings at $8.35 EPS.

Other equities research analysts also recently issued research reports about the company. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a report on Friday, July 11th. Bank of America lowered their price target on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Robert W. Baird set a $247.00 price target on Danaher in a report on Wednesday. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Danaher Price Performance

Shares of NYSE DHR opened at $222.62 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.22 and a current ratio of 1.52. The company has a market cap of $157.25 billion, a PE ratio of 45.90, a P/E/G ratio of 3.31 and a beta of 0.77. The business has a 50-day simple moving average of $202.49 and a two-hundred day simple moving average of $198.02. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $258.23.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the company earned $1.71 earnings per share. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Insider Activity

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of DHR. GAMMA Investing LLC raised its position in Danaher by 22.2% during the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares in the last quarter. Pacific Capital Partners Ltd purchased a new position in Danaher during the first quarter valued at approximately $7,175,000. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. International Assets Investment Management LLC raised its position in Danaher by 39.5% during the first quarter. International Assets Investment Management LLC now owns 2,191 shares of the conglomerate’s stock valued at $449,000 after acquiring an additional 620 shares in the last quarter. Finally, Global Assets Advisory LLC purchased a new position in Danaher during the first quarter valued at approximately $312,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.